Fundamental dimension Equity attribute | CFICPeer $8.32▲+21.82% Cap $18.24MP/E -83.2x QuantScore26/100 | BRBWPeer $16.000.00% Cap $23.62MP/E 12.1x QuantScore59/100 | CBOFLeader $2.27▼-1.30% Cap $23.19MP/E 6.3x QuantScore62/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
31/100 |
76/100 |
58/100 |
Valuation Multiples, PEG & DCF upside | 22/100 | 90/100 | 95/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 17/100 | 37/100 |
Growth Revenue / earnings growth & margins | 32/100 | 54/100 | 59/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -83.2x | 12.1x | 6.3x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | — | 17.5x | 14.1x |
Price / Sales | 1.8x | 1.4x | 1.4x |
Price / Free Cash Flow | 38.5x | 5.3x | 4.4x |
PEG ratio | -0.83 | -3.85 | 0.06 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 5 / 9 | 5 / 9 |
Altman Z-Score | 0.04 (Distress) | 0.12 (Distress) | 0.12 (Distress) |
Total debt / equity | 0.06 | 1.37 | 1.21 |
Quick ratio | — | 0.1x | 0.1x |
Interest coverage | -0.9x | -0.0x | 18.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +7.3% | +9.8% | +14.3% |
Net income growth YoY | -587.2% | +14.8% | +21.0% |
Gross margin (TTM) | 100.0% | 100.0% | 100.0% |
Operating margin (FY) | -3.7% | -0.2% | 29.8% |
FCF margin (FY) | 4.7% | 27.3% | 32.0% |
5. Trailing price performancePrice change over period |
1M return | +23.8% | +21.2% | 0.0% |
3M return | +17.0% | -0.7% | -5.4% |
6M return | +9.5% | -2.7% | +0.4% |
Year to date | -10.2% | -5.9% | -9.2% |
1Y return | -11.1% | +8.1% | -9.2% |
3Y return | -24.4% | +107.2% | -13.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | — — | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |